CNS Exosomes-Mediated Adaptive Immunity in Alzheimer's Disease (AD)
中枢神经系统外泌体介导的阿尔茨海默病 (AD) 适应性免疫
基本信息
- 批准号:10515429
- 负责人:
- 金额:$ 93.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAlzheimer&aposs disease antigenAlzheimer&aposs disease brainAlzheimer&aposs disease modelAnimal Disease ModelsAntigensAstrocytesAutopsyAxonB-LymphocytesBiochemicalBloodBlood CirculationBlood VesselsBrainCD8-Positive T-LymphocytesCellsClonalityDataDetectionEndosomesEngineeringFutureGenesGlutamate TransporterHumanImmuneImmune responseIn VitroInfiltrationInjectionsLabelMediatingMedicalMicrogliaMolecularMultivesicular BodyMusMutateMyeloid CellsNatural ImmunityNeurodegenerative DisordersNeurofibrillary TanglesNeuronsPathogenesisPathologicPathway interactionsPeripheralPlayPopulationProteinsReporterRoleSenile PlaquesSerumSignal TransductionSocietiesT-Cell ActivationT-LymphocyteTravelVesicleVirusadaptive immunityaquaporin 4basebrain parenchymacell typeexosomeextracellularextracellular vesiclesfoothyperphosphorylated tauimmunogenicin vivoin vivo two-photon imagingmouse geneticsmyelinationneoplastic cellneuroinflammationnovelsingle-cell RNA sequencingtherapeutic developmenttool
项目摘要
Abstract
Alzheimer’s disease (AD) remains one of the most unmet medical challenges in our society. In the AD,
neuroinflammation has been increasingly recognized to play a central role in the pathogenesis of AD, in addition
to extracellular amyloid plaques and hyperphosphorylated tau based neurofibrillary tangles. Although the role of
innate immunity especially represented by microglia is well-established in AD, it is far less understood and
established about whether and how the T or B cell-mediated adaptive immunity is involved in AD pathogenesis.
In particular, whether there are brain- and AD-specific antigens to activate adaptive immunity and how these
antigens travel to peripheral remain to be investigated. Exosomes (size 40-100 nm), a major type of secreted
extracellular vesicles (EVs), are derived from intraluminal vesicles (ILV) that are budded inwardly from the early
endosomal compartment and are released from multiple vesicular bodies (MVB) during the maturation of
endosomes. EVs and exosomes secreted from various CNS cell types have emerged as a novel and important
intercellular pathway in the. Exosome-mediated secretion has also been implicated in initiation and propagation
in AD. Although exosomes secreted from various peripheral cell types especially immune and tumor cells trigger
immune responses, whether and how CNS-derived exosomes are immunogenic remains unexplored.
By employing cell-type specific ILV/exosome reporter (hCD63-GFPf/f) mice we recently generated, we
showed that astroglia-derived exosomes are associated with Aquaporin 4+ (Aqp4+) perivascular end feet/blood
vessel in the brain. hCD63-GFP+ astroglial exosomes can also be detected in blood serum of LPS-injected (but
not control) Glast-CreER+CD63-GFPf/+ mice. Excitingly, exosomes secreted from “reactive” astroglia (RAEs)
strongly activate CD4+ and CD8+ T cells in vitro and in vivo. Based on previous studies and our preliminary
results, we propose to investigate the following aims: 1) Determine pathological efflux of CNS cell-type specific
exosomes from brain and their entry into peripheral circulation in AD models; 2) Determine antigenicity of AD-
relevant astroglial exosomes in activating T cells in vitro and in vivo. We have generated a large amount of
preliminary data to support our rationales and to demonstrate feasibility for proposed aims. We will employ
mouse genetics, virus injections, immunohistochemical (IHC) analysis and in vivo two-photon imaging, primary
cultures, FACS, and biochemical approaches to investigate these two aims. Results from this project will
determine the efflux changes of neuron or astroglial exosomes from the brain and these exosomes’ entry into
peripheral circulation in AD models. In addition, our current study will investigate how T cells respond to “reactive”
astroglial exosomes. As reactive astroglia is commonly observed in neurodegenerative diseases including AD,
this will potentially unveil new mechanisms how T cells are involved in AD pathogenesis and help define specific
brain signals to activate T cells in AD, which subsequently facilitate the therapeutic development.
抽象的
阿尔茨海默病(AD)仍然是我们社会中最未解决的医学挑战之一。在公元,
人们越来越认识到神经炎症在 AD 的发病机制中发挥着核心作用,此外
细胞外淀粉样斑块和基于过度磷酸化 tau 的神经原纤维缠结。虽然角色
先天免疫,特别是以小胶质细胞为代表的先天免疫在 AD 中已得到充分证实,但人们对它的了解却少得多,而且
确定 T 或 B 细胞介导的适应性免疫是否以及如何参与 AD 发病机制。
特别是,是否存在大脑和 AD 特异性抗原来激活适应性免疫以及这些抗原如何激活
抗原传播到外周仍有待研究。外泌体(大小 40-100 nm),一种主要的分泌型
细胞外囊泡(EV)源自管腔内囊泡(ILV),从早期向内出芽
内体区室并在成熟过程中从多个囊泡体(MVB)中释放出来
内体。由各种 CNS 细胞类型分泌的 EV 和外泌体已成为一种新颖且重要的
细胞间通路中。外泌体介导的分泌也与起始和传播有关
在公元。尽管外泌体由各种外周细胞类型尤其是免疫细胞和肿瘤细胞分泌
免疫反应,中枢神经系统衍生的外泌体是否以及如何具有免疫原性仍有待探索。
通过使用我们最近培育的细胞类型特异性 ILV/外泌体报告基因 (hCD63-GFPf/f) 小鼠,我们
显示星形胶质细胞衍生的外泌体与水通道蛋白 4+ (Aqp4+) 血管周围末端脚/血液相关
大脑中的血管。 hCD63-GFP+ 星形胶质细胞外泌体也可以在注射 LPS 的血清中检测到(但
非对照)Glast-CreER+CD63-GFPf/+ 小鼠。令人兴奋的是,“反应性”星形胶质细胞(RAE)分泌的外泌体
在体外和体内强烈激活 CD4+ 和 CD8+ T 细胞。根据之前的研究和我们的初步
根据结果,我们建议研究以下目标:1)确定中枢神经系统细胞类型特异性的病理流出
AD 模型中来自大脑的外泌体及其进入外周循环; 2) 确定AD-的抗原性
相关星形胶质细胞外泌体在体外和体内激活 T 细胞的作用。我们已经产生了大量的
初步数据支持我们的理由并证明拟议目标的可行性。我们将聘用
小鼠遗传学、病毒注射、免疫组织化学 (IHC) 分析和体内双光子成像、初级
培养、FACS 和生化方法来研究这两个目标。该项目的结果将
确定神经元或星形胶质细胞外泌体从大脑的流出变化以及这些外泌体进入
AD 模型中的外周循环。此外,我们目前的研究将调查T细胞如何应对“反应性”
星形胶质细胞外泌体。由于反应性星形胶质细胞在包括 AD 在内的神经退行性疾病中常见,
这将有可能揭示 T 细胞如何参与 AD 发病机制的新机制,并帮助定义特定的
大脑发出信号来激活 AD 中的 T 细胞,从而促进治疗的发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALEXEI DEGTEREV其他文献
ALEXEI DEGTEREV的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ALEXEI DEGTEREV', 18)}}的其他基金
Analyzing Oligodendrocytes-Derived Exosomes in Mouse Models of Multiple Sclerosis
分析多发性硬化症小鼠模型中少突胶质细胞来源的外泌体
- 批准号:
10526691 - 财政年份:2022
- 资助金额:
$ 93.36万 - 项目类别:
CNS Exosomes-Mediated Adaptive Immunity in Alzheimer's Disease (AD)
中枢神经系统外泌体介导的阿尔茨海默病 (AD) 适应性免疫
- 批准号:
10685315 - 财政年份:2022
- 资助金额:
$ 93.36万 - 项目类别:
Analyzing Oligodendrocytes-Derived Exosomes in Mouse Models of Multiple Sclerosis
分析多发性硬化症小鼠模型中少突胶质细胞来源的外泌体
- 批准号:
10622532 - 财政年份:2022
- 资助金额:
$ 93.36万 - 项目类别:
Mechanistic analysis of necrostatins: specific inhibitors of programmed necrosis
坏死他汀的机制分析:程序性坏死的特异性抑制剂
- 批准号:
8206661 - 财政年份:2009
- 资助金额:
$ 93.36万 - 项目类别:
Mechanistic analysis of necrostatins: specific inhibitors of programmed necrosis
坏死他汀的机制分析:程序性坏死的特异性抑制剂
- 批准号:
7893300 - 财政年份:2009
- 资助金额:
$ 93.36万 - 项目类别:
Mechanistic analysis of necrostatins: specific inhibitors of programmed necrosis
坏死他汀的机制分析:程序性坏死的特异性抑制剂
- 批准号:
8025946 - 财政年份:2009
- 资助金额:
$ 93.36万 - 项目类别:
Mechanistic analysis of necrostatins: specific inhibitors of programmed necrosis
坏死他汀的机制分析:程序性坏死的特异性抑制剂
- 批准号:
7767696 - 财政年份:2009
- 资助金额:
$ 93.36万 - 项目类别:
Molecular and functional analysis of necroptosis initiation complex
坏死性凋亡起始复合物的分子和功能分析
- 批准号:
8305588 - 财政年份:2008
- 资助金额:
$ 93.36万 - 项目类别:
Molecular and functional analysis of necroptosis initiation complex
坏死性凋亡起始复合物的分子和功能分析
- 批准号:
7527738 - 财政年份:2008
- 资助金额:
$ 93.36万 - 项目类别:
Molecular and functional analysis of necroptosis initiation complex
坏死性凋亡起始复合物的分子和功能分析
- 批准号:
8118275 - 财政年份:2008
- 资助金额:
$ 93.36万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 93.36万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 93.36万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 93.36万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 93.36万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 93.36万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 93.36万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 93.36万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 93.36万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 93.36万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 93.36万 - 项目类别:














{{item.name}}会员




